Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · Real-Time Price · USD
33.23
-0.43 (-1.28%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Celldex Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 2,607 | 1,805 | 1,677 | 2,169 | 2,099 | 1,803 | |
| Market Cap Growth | 146.39% | 7.65% | -22.71% | 3.32% | 16.42% | 160.10% | |
| Enterprise Value | 2,091 | 1,224 | 924 | 1,936 | 1,779 | 1,383 | |
| Last Close Price | 33.23 | 27.16 | 25.27 | 39.66 | 44.57 | 38.64 | |
| PS Ratio | 1687.59 | 1168.13 | 238.82 | 315.12 | 890.64 | 387.68 | |
| PB Ratio | 4.19 | 3.42 | 2.24 | 5.05 | 6.44 | 4.30 | |
| P/TBV Ratio | 5.21 | 3.61 | 2.33 | 5.40 | 7.02 | 4.60 | |
| EV/Sales Ratio | 1353.46 | 792.34 | 131.57 | 281.34 | 754.94 | 297.37 | |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Net Debt / Equity Ratio | -0.98 | -0.98 | -0.97 | -0.98 | -0.92 | -0.97 | |
| Net Debt / EBITDA Ratio | 1.82 | 1.82 | 3.76 | 3.03 | 2.89 | 6.13 | |
| Net Debt / FCF Ratio | 2.42 | 2.42 | 4.52 | 3.86 | 2.85 | 6.52 | |
| Asset Turnover | 0.00 | 0.00 | 0.01 | 0.02 | 0.01 | 0.01 | |
| Quick Ratio | 10.21 | 10.21 | 18.38 | 13.69 | 16.41 | 24.71 | |
| Current Ratio | 10.49 | 10.49 | 18.92 | 13.87 | 17.07 | 24.86 | |
| Return on Equity (ROE) | -40.62% | -40.62% | -26.84% | -37.45% | -30.13% | -22.43% | |
| Return on Assets (ROA) | -26.12% | -26.12% | -19.38% | -21.70% | -16.79% | -12.70% | |
| Return on Capital Employed (ROCE) | -54.00% | -54.00% | -25.90% | -32.70% | -32.10% | -16.20% | |
| Earnings Yield | -9.92% | -14.34% | -9.42% | -6.52% | -5.35% | -3.91% | |
| FCF Yield | -8.19% | -11.84% | -9.53% | -5.03% | -5.03% | -3.45% | |
| Buyback Yield / Dilution | -3.15% | -3.15% | -32.91% | -3.33% | -9.37% | -44.64% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.